APTA.L
Aptamer Group plc [APTA.L] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
APTA.L Stock Summary
Top 10 Correlated ETFs
APTA.L
Top 10 Correlated Stocks
APTA.L
In the News
APTA.L Financial details
Company Rating
-
Market Cap
2.55M
Income
-10.96M
Revenue
2.56M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
37
Optionable
No
Shortable
Yes
Earnings
15 Oct 2024
P/E
0
Forward P/E
-
PEG
-
P/S
3.1
P/B
-
P/C
-
P/FCF
-0.89
Quick Ratio
0.14
Current Ratio
0.97
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.14
EPS next Y
-
EPS next Q
-
EPS this Y
263.04%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
75.54%
Revenue last 5Y
12.17%
Revenue Q/Q
-59.57%
EPS Q/Q
-93.36%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-285%
ROE
-188%
ROC
-7.35%
Gross Margin
20%
Oper. Margin
-466%
Profit Margin
-447%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.45-30.5
52W High
-
52W Low
-
RSI
70
Rel Volume
2.56
Avg Volume
6.48M
Volume
16.6M
Perf Week
43.14%
Perf Month
17.74%
Perf Quarter
58.7%
Perf Half Y
62.22%
-
-
-
-
Beta
-0.418
-
-
Volatility
0.04%, 0.02%
Prev Close
12.31%
Price
0.365
Change
17.74%
Company Profile
- Volume Average 6.48M
- Market Capitalization 2.55M
- Employee 37
- CEO Dr. Arron Craig Tolley
- Headquarters York,GB
- IPO Date 2021-12-22
-
Website
https://aptamergroup.com 
Aptamer Group plc provides binders for research, diagnostics, and therapeutics in the United Kingdom and internationally. The company's binders engineered to address issues which founds with molecules, such as antibodies; and offers solutions to bioprocessing, diagnostic, and pharmaceutical scientists. It serves pharma companies, diagnostic development companies, and research institutes. The company was incorporated in 2014 and is based in York, the United Kingdom.
